Skip to content
ppharmaranks
Menu

Best treatments for coronary thrombosis

3 products may treat coronary thrombosis, spanning FDA drug classes such as anti-coagulant, unfractionated heparin. The current highest-rated option is tnkase. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for coronary thrombosis, 2 are available as lower-cost generics, spanning classes such as anti-coagulant, unfractionated heparin. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for coronary thrombosis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for coronary thrombosis: 1. Tnkase · 2. Heparin Sodium 1,000 Units in Sodium Chloride 0.9% in Plastic Container · 3. Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container

Top-rated treatments for coronary thrombosis, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
268/100$2View →
368/100$2View →

Narrow by drug class

Explore the class hubs: anti-coagulant

Full ranking · 3 treatments

Frequently asked

What treats coronary thrombosis?
Our catalog lists 3 products that may treat coronary thrombosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is tnkase.
What is the best-rated treatment for coronary thrombosis?
By our independent recall-safety rating — not an efficacy measure — tnkase ranks highest among the products we list for coronary thrombosis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat coronary thrombosis?
Treatments for coronary thrombosis span FDA drug classes including anti-coagulant, unfractionated heparin. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.